Fosun Pharma launches dual share incentive plans
Shanghai Fosun Pharmaceutical announced two parallel incentive schemes for 2025: an A-share stock option plan and an H-share restricted share unit plan.
The A-share plan proposes granting up to 5,726,100 stock options, with a first grant of 4,580,900 options at an exercise price of 27.93 yuan per share.
The H-share plan offers up to 13,370,500 restricted share units, with an initial grant of 10,696,400 units, purchasable at 1.00 yuan per unit after vesting.
Both initiatives will be funded by repurchased shares.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Shanghai Fosun Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime